Site US10012 — Mount Kisco, New York

Site US10012 is a clinical research site located in Mount Kisco, New York, United States 10549.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Site US10012 has participated in 1 clinical trials.

Therapeutic areas: Non-small Cell Lung Cancer (NSCLC).

Sponsors: Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US10012?

Site US10012 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US10012 conducted?

Site US10012 has 1 clinical trials on record. Their work covers Non-small Cell Lung Cancer (NSCLC).

Is Site US10012 accredited by Crixeo Health?

Site US10012 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US10012?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.